Context‐Specific Montreal Cognitive Assessment Cutoffs for Cognitive Impairment in Parkinson's Disease
BACKGROUND: The Montreal Cognitive Assessment (MoCA) is widely used in Parkinson's disease (PD) research to measure cognition, but published cutoffs for mild cognitive impairment (PD-MCI) and dementia (PDD) vary. OBJECTIVE: To identify context-specific MoCA cutoffs for PD-MCI, PDD, and impairment on formal neuropsychological testing, and to assess whether combining MoCA with routinely collected clinical measures improves discrimination. METHODS: Data from 1094 people with PD were analyzed. 39.0% were diagnosed with PD-MCI, 6.2% with PDD. Normative ranges for five neuropsychological tests were derived from healthy controls. Mixed-effects logistic regression accounted for repeated measures and predicted (1) impairment on formal neuropsychological testing and (2) clinician-derived cognitive diagnoses. Cutoffs were derived using Youden's J, a prevalence-matching approach (cutoff where the proportion below threshold equals outcome prevalence), and standard screening and diagnostic criteria. RESULTS: Education-adjusted MoCA predicted impairment in two or more cognitive domains with an AUC of 0.86 (95% CI: 0.84-0.88). A cutoff of ≤24 maximized Youden's J (sensitivity 74.7% [70.5-79.3], specificity 83.1% [82.0-84.2]); the prevalence-matched cutoff was ≤21. For PD-MCI, the Youden's J cutoff was ≤25 and the prevalence-matched cutoff ≤24; PDD cutoffs were ≤23 and ≤17. Functional impairment (MDS-UPDRS 1.1) showed greater concordance with clinician-assigned diagnosis than MoCA alone. CONCLUSION: Optimal MoCA cutoffs vary by intended use. For research stratification, prevalence-matched cutoffs can align classification with observed outcome prevalence. Generalizability may be limited, particularly to routine clinical populations. Cutoffs derived in the PPMI cohort may over-identify impairment in broader populations.
Authors
- Sanjay Manohar (ORCID: https://orcid.org/0000-0003-0735-4349)
- Jamil Razzaque (ORCID: https://orcid.org/0000-0002-6700-1177)
- Jessica Welch (ORCID: https://orcid.org/0000-0003-0754-9285)
- Johannes Christian Klein (ORCID: https://orcid.org/0000-0002-8553-2801)
- Yoav Ben‐Shlomo (ORCID: https://orcid.org/0000-0001-6648-3007)
- Tanja Zerenner (ORCID: https://orcid.org/0000-0002-4672-5619)
- Tamir Eisenstein (ORCID: https://orcid.org/0009-0007-2729-217X)
- Karolien Groenewald (ORCID: https://orcid.org/0009-0009-5511-579X)
- Michael A Lawton (ORCID: https://orcid.org/0000-0002-3419-0354)
- Ludo van Hillegondsberg (ORCID: https://orcid.org/0000-0003-2641-3527)
- Daniel Weintraub (ORCID: https://orcid.org/0000-0003-0633-7168)
- Michele T Hu (ORCID: https://orcid.org/0000-0001-6382-5841)
- Falah Al Hajraf (ORCID: https://orcid.org/0000-0002-0559-4536)
Institutions
- Nuffield Orthopaedic Centre (GB)
- University of Bristol (GB)
- Kuwait University (KW)
- University of Oxford (GB)
- University of Pennsylvania (US)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/mdc3.70875
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Parkinson's UK
- NIHR Oxford Biomedical Research Centre